Non-random involvement of chromosome 13 in patients with persistent or relapsed disease after bone-marrow transplantation for chronic myeloid leukemia

Genes Chromosomes and Cancer

Volumn 27, Issue 3, 2000, Pages 278-284

  Chase, Andrew ^a   Pickard, Julie ^a   Szydlo, Richard ^a   Coulthard, Stephanie ^a   Goldman, John M ^a   Cross, Nicholas C P ^a  

^a IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BONE MARROW TRANSPLANTATION; CANCER RECURRENCE; CHROMOSOME 13; CHROMOSOME ANALYSIS; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; CYTOGENETICS; FLUORESCENCE IN SITU HYBRIDIZATION; GENE TRANSLOCATION; HUMAN; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

BONE MARROW TRANSPLANTATION; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 13; CLONE CELLS; FEMALE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; KARYOTYPING; LEUKEMIA, MYELOID, CHRONIC; MALE; RECURRENCE; TRANSLOCATION, GENETIC;

EID: 0033984975     PISSN: 10452257     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2264(200003)27:3<278::AID-GCC8>3.0.CO;2-H     Document Type: Article

References (16)

1. 1-positive chronic myelogenous leukemia. Bone Marrow Transplant 5:119-127.
2. Altman D. 1991. Practical Statistics for Medical Research. London: Chapman and Hall. 231 p.
3. Chumakov IM, Rigault P, Le Gall I, Bellanné-Chantelot C, Billault A, Guillou S, Soularue O, Guasconi G, Poullier E, Gros I, Belova M, Sambucy J-L, Susini L, Gervy P, Glibert F, Beaufils S, Bui H, Massart C, De Tand M-F, Dukasz F, Lecoulant S, Ougen P, Perrot V, Saumier M, Soravito C, Bahouayila R, Cohen-Akenine A, Barrillot E, Bertrand S, Codani J-J, Caterina D, Georges I, Lacroix B, Lucotte G, Sahbatou M, Schmit C, Sangouard M, Tubacher E, Dib C, Fauré S, Fizames C, Gyapay G, Millasseau P, Nguyen S, Musalet D, Vignal A, Morissette J, Menninger J, Leiman J, Desai T, Banks A, Brayward P, Ward D, Hudson T, Gerety S, Foote S, Stein L, Page DC, Lander ES, Weissenbach J, Le Paslier D, Cohen D. 1995. A YAC contig map of the human genome. Nature 377:175-297.
4. Clift RA, Anasetti C. 1997. Allografting for chronic myeloid leukemia. Baillières Clin Haematol 10:319-336.
5. Corcoran MM, Rasool O, Liu Y, Lyengar A, Grander D, Ibbotson RE, Merup M, Wu X, Brodyansky V, Gardiner AC, Juliusson G, Chapman RM, Ivanova G, Tiller M, Gahrton G, Yankovsky N, Zabarovsky E, Oscier DG, Einhorn S. 1988. Detailed molecular delineation pf 13q14.3 loss in B-cell chronic lymphocytic leukemia. Blood 91:1382-1390.
6. Da Silva MAP, Heerema NA, Lowe LR, Tricot G, Jensen J. 1988. Cytogenetic patterns following bone marrow transplantation for chronic granulocytic leukemia. Cancer Genet Cytogenet 36:35-44.
7. ISCN. 1995. An international system for human cytogenetic nomenclature In: Mitelman F, editor. Basel: S. Karger.
8. Kempski H, MacDonald D, Michalski AI, Roberts-T, Goldman JM, Cross NC, Cowell JK. 1995. Localization of the 8;13 translocation breakpoint associated with myeloproliferative disease to a 1.5 Mbp region of chromosome 13. Genes Chromosomes Cancer 12:283-287.
9. La Starza R, Wlodarska AA, Falzetti B, Crescenzi B, Martelli MF, Van den Berghe H, Mecucci C. 1998. Molecular delineation of 13q deletion boundaries in 20 patients with myeloid malignancies. Blood 91:231-237.
10. Lichter P, Cremer T. 1992. Chromosome analysis by non-isotopic in situ hybridization. In: Rooney D, Czepulkowski B, editors. Human cytogenetics: a practical approach. Vol I. New York:Oxford University Press. p 157-192.
11. Offit K, Burns JP, Cunningham I, Jhanwar SC, Black P, Kernan NA, O'Reilly RJ, Chaganti RSK. 1990. Cytogenetic analysis of chimerism and leukemia relapse in chronic myelogenous leukemia patients after T cell-depleted bone marrow transplantation. Blood 75:1346-1355.
12. Rooney DE, Czepulkowski BH, editors. 1992. Human cytogenetics: a practical approach. Vol. II. New York:Oxford University Press.
13. Sessarego M, Frassoni F, Defferrari R, Bacigalupo A, Fugazza G, Mareni C, Bruzzone R, Dejana A, Ajmar F. 1991. Karyotype evolution of Ph positive chronic myelogenous leukemia patients relapsed in advanced phases of the disease after allogeneic bone marrow transplantation. Cancer Genet Cytogenet 57:69-78.
14. Speck B, Bortin MM, Champlin R, Goldman JM, Herzig RH, McGlave PB, Messner HA, Weiner RS, Rimm AA. 1984. Allogeneic bone marrow transplantation for chronic myelogenous leukaemia. Lancet i:665-668.
15. Stilgenbauer S, Nickolenko J, Wilhelm J, Wolf S, Weitz S, Döhner K, Boehm T, Döhner H, Lichter P. 1998. Expressed sequences as candidates for a novel tumor suppressor gene at band 13q14 in B-cell chronic lymphocytic leukemia and mantle cell lymphoma. Oncogene 16:1891-1897.
16. Webber L, Garson OM. 1983. Fluorodeoxyuridine synchronization of bone marrow cultures. Cancer Genet Cytogenet 8:123-132.